FSANZ Approves New Enzyme Processing Aids, Signals Regulatory Focus Down Under

Expanding the Tool Kit for Processing Aids

The Food Standards Australia New Zealand (FSANZ) Board recently convened to deliberate on critical standards matters, with several decisions set to impact the food and supplement manufacturing landscape. Among the key approvals were three new enzyme-based processing aids, offering fresh avenues for our industry to refine production processes.

Two applications from Novozymes Australia Pty Ltd, A1292 and A1293, received the green light. These permit the use of phospholipase C and phosphoinositide phospholipase C, both derived from Bacillus licheniformis, as processing aids. Their primary function? Degumming fats and oils by efficiently removing phospholipids during processing. For manufacturers like us, this represents a valuable enhancement in oil purification, potentially leading to higher quality ingredients for various formulations.

Equally significant was the approval of Application A1328 from IFF Australia Pty Ltd (trading as Danisco Australia Pty Ltd), allowing the use of Aminopeptidase Y from Trichoderma reesei. This enzyme is sanctioned for use in protein and yeast processing, as well as flavour production. From a formulation standpoint, such enzymes can unlock new possibilities for developing products with improved protein functionality or enhanced flavour profiles. These approvals underscore a continuing trend towards leveraging biochemical innovation for manufacturing efficiency and quality improvement.

Strategic Shifts and Future Regulatory Priorities

Beyond the immediate approvals, the FSANZ Board meeting also provided valuable insights into the broader strategic direction influencing food and supplement regulation in Australia and New Zealand. A notable development was the engagement with the Australian Minister for Agriculture, Fisheries and Forestry, the Hon Julie Collins MP. Their strategic discussion centred on the National Food Security Strategy, signalling a strong governmental focus on creating a resilient and sustainable food system.

Brand owners and manufacturers should interpret this as a clear indication that future regulatory changes may increasingly integrate considerations beyond just immediate safety and quality. Expect a rising emphasis on supply chain reliability, sustainable sourcing, and environmentally sound production practices. This aligns with global trends where consumers and regulators are demanding greater transparency and responsibility from the industry.

Ongoing Reviews: What to Monitor

The Board also received updates on several ongoing proposals and projects that could shape the future regulatory environment:

• Proposal P1056: Caffeine Review: This is particularly pertinent for the sports nutrition and energy supplement sectors. Any changes to caffeine allowances or labelling requirements will necessitate careful review of formulations and marketing claims.
• Commercial Foods for Infants and Young Children: While not directly impacting adult supplements, changes here often foreshadow broader regulatory shifts concerning ingredient safety and nutritional standards that can influence adjacent categories.
• Health Star Rating and Nutrition Information Panel Review: These reviews are crucial for all packaged food and supplement products. Harmonisation or changes to these systems will undoubtedly impact product communication and consumer perception.

For supplement manufacturers, staying abreast of these ongoing discussions is vital to ensure proactive compliance and strategic product development. The integration of economic analysis into regulatory decision-making, as discussed with the Office of Impact Analysis, also suggests a more rigorous approach to assessing the costs and benefits of new regulations to the industry.

This trend is being actively addressed by UK manufacturing partners including Supplement Factory.